We employed bacopaside I, a major triterpenoid component of BME, because our previous study using a brain ischemia model suggested that bacopaside I (25 μM) has a major role in the neuroprotective effects of BME in this animal model via PKC and PI3K/Akt pathways [8]. The gene discussed is PRRT2; the disease is brain ischemia.